Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin A Sokolowski

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nutrients|October 14, 2017
Dosis Facit Sanitatem-Concentration-Dependent Effects of Resveratrol on MitochondriaCorina T Madreiter-Sokolowski, Armin A Sokolowski, Wolfgang F Graier
Frontiers in Cell and Developmental Biology|February 22, 2021
Dynamic Control of Mitochondrial Ca<sup>2+</sup> Levels as a Survival Strategy of Cancer CellsCorina T Madreiter-Sokolowski, Benjamin Gottschalk, Armin A Sokolowski, et al.
Genes|March 17, 2018
Targeting Mitochondria to Counteract Age-Related Cellular DysfunctionCorina T Madreiter-Sokolowski, Armin A Sokolowski, Markus Waldeck-Weiermair, et al.
Oncotarget|November 9, 2017
UCP2 and PRMT1 are key prognostic markers for lung carcinoma patientsCorina T Madreiter-Sokolowski, Balázs Győrffy, Christiane Klec, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nutrients|October 14, 2017
Dosis Facit Sanitatem-Concentration-Dependent Effects of Resveratrol on MitochondriaCorina T Madreiter-Sokolowski, Armin A Sokolowski, Wolfgang F Graier
Frontiers in Cell and Developmental Biology|February 22, 2021
Dynamic Control of Mitochondrial Ca<sup>2+</sup> Levels as a Survival Strategy of Cancer CellsCorina T Madreiter-Sokolowski, Benjamin Gottschalk, Armin A Sokolowski, et al.
Genes|March 17, 2018
Targeting Mitochondria to Counteract Age-Related Cellular DysfunctionCorina T Madreiter-Sokolowski, Armin A Sokolowski, Markus Waldeck-Weiermair, et al.
Oncotarget|November 9, 2017
UCP2 and PRMT1 are key prognostic markers for lung carcinoma patientsCorina T Madreiter-Sokolowski, Balázs Győrffy, Christiane Klec, et al.
Pageof 1